FDA Warning Letter — AstraZeneca Pharmaceuticals LP
The FDA took a Warning Letter action against AstraZeneca Pharmaceuticals LP on August 4, 2023 (Wilmington, DE). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- AstraZeneca Pharmaceuticals LP
- Date
- August 4, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Center
- CDER
- Location
- Wilmington, DE (United States)